SOLB Solvay SA

Solvay and Orbia join forces to create a Joint Venture in North America to supply critical materials to the battery market

Solvay and Orbia join forces to create a Joint Venture in North America to supply critical materials to the battery market

Solvay and Orbia join forces to create a Joint Venture in North America to supply critical materials to the battery market

Joint venture will create the largest PVDF production facility for battery materials in the region. The total investment is estimated around 850 million USD, partially funded by a grant to Solvay from the U.S. Department of Energy for a total of 178 million USD.

Brussels and Boston - November 3, 2022 - 7 a.m. CET

Solvay and Orbia today announced their entry into a joint venture framework agreement to create a partnership for the production of suspension-grade polyvinylidene fluoride (PVDF), creating the largest capacity in North America.

With more than half, demand for lithium-ion batteries and PVDF, a thermoplastic fluoropolymer used as a lithium-ion binder and separator coating, is revving up. The Solvay-Orbia joint venture would fill a significant supply gap and will build upon favorable regulatory conditions promoting regional production and material security. Solvay, a global leader in PVDF, brings process technology and unparalleled global market know-how to this venture. With a vertically-integrated value chain and material holdings, Orbia’s Fluorinated Solutions business Koura and Polymer Solutions business Vestolit will supply hydrofluoric acid, vinyl chloride monomer (VCM) and chlorine respectively. In combination, Solvay’s Solef® PVDF innovations and Orbia’s raw material assets and production expertise will enable delivery of PVDF that optimizes energy storage efficiency by increasing battery energy-density, safety and power.

“We are delighted to partner with Orbia on this exciting opportunity to expand our battery solutions into North America, with strong support by the U.S. Department of Energy,” said Ilham Kadri, CEO of Solvay. “This significant milestone in our electrification strategy enhances our global leadership and contributes to the establishment of the battery supply chain infrastructure in the United States. This decision follows our previously announced investment in Tavaux, France. These investments extend our ambition to grow global sales to the automotive market from €800 million in 2021 to over €3 billion by 2030.”

Said Sameer Bharadwaj, CEO of Orbia, “Our partnership with Solvay marks a key milestone for our business and our role in enabling the North American energy transition. Together with Solvay, Orbia’s unique position integrated into both the fluorine and vinyl chains, helps us to bring a cost competitive battery supply chain to the U.S., just as we maintain our commitment to developing sustainable solutions that can advance life globally. Along with our previously announced Department of Energy grant to produce LiPF6 electrolyte salts in North America, this investment will put us in a leadership position to provide a secure source for fluorinated lithium-ion battery additives as well as local jobs.”

The total investment is estimated to be around $850 million, and is expected to be funded in part by a grant awarded by the U.S. Department of Energy of $178 million to Solvay to build a facility in Augusta, Georgia. Solvay and Orbia intend to use two production sites, one for raw materials and the other for finished product, located in the southeastern United States. Both plants are expected to be fully operational by 2026. Commencement of the joint venture is subject to finalizing and entering into definitive agreements between the parties and satisfaction of customary conditions, including obtaining regulatory approvals.

Forward-looking information

This press release may contain forward-looking statements. Forward-looking statements describe expectations, plans, strategies, objectives, future events or intentions. The realization of the forward-looking statements contained in this release is subject to risks and uncertainties due to a number of factors, including general economic factors, fluctuations in interest rates and foreign exchange rates, changes in market conditions, product competition, the nature of product development, the impact of acquisitions and divestitures, restructurings, product retirements, the regulatory approval process, global R&I project scenarios and other unusual items. Therefore, actual results or future events may differ materially from those expressed or implied in such forward-looking statements. If known or unknown risks or uncertainties materialize, or if our assumptions prove incorrect, actual results may differ materially from those projected. Solvay does not undertake to update or revise publicly any forward-looking statements.

 

Attachment



EN
03/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

Stijn Demeester
  • Stijn Demeester

Solvay/Expectations reset, yield remains attractive/BUY

We update our model and lower our Und. EBITDA estimates by c.12% to reflect Solvay's 2Q25 results and lowered guidance. We reduce our target price to €30 per share from €33.50 yet keep our BUY on the back of Solvay's attractive dividend yield.

Solvay SA: 1 director

A director at Solvay SA bought 1,083 shares at 27.740EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Wim Hoste
  • Wim Hoste

Solvay Feedback conference call

Below are the key highlights from the conference call. Solvay's 1Q25 uEBITDA dropped 15% to € 230m, in line with the recent profit warning. Solvay reiterated the (recently cut) FY25 underlying EBITDA guidance of € 880-930m (c. -12% at midpoint vs the previous € 1.0-1.05bn range), citing continued soft demand in a context of tariff and geopolitical uncertainty. Solvay had already stated to maintain FCF guidance of c. € 300m (on the back of more prudent capex spending) which however still means th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch